Last quarter (Q3 2023), Adaptogenics Health Corp.'s total revenue was C$―, a decrease of ― from the same quarter last year. In Q3, Adaptogenics Health Corp.'s net income was C$-30.86K. See Adaptogenics Health Corp.’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Mar 23
Total Revenue
-
Cost of Revenue
-
Gross Profit
-
Operating Expense
C$ 270.65K
Operating Income
C$ -270.65K
Net Non Operating Interest Income Expense
C$ 5.04K
Other Income Expense
-
Pretax Income
C$ -265.61K
Tax Provision
-
Earnings From Equity Interest Net Of Tax
-
Net Income Common Stockholders
C$ -265.61K
Basic EPS
C$ -0.02
Diluted EPS
C$ -0.02
Basic Average Shares
C$ 16.40M
Diluted Average Shares
C$ 16.40M
Dividend Per Share
-
Total Operating Income As Reported
-
Reported Normalized Basic E P S
-
Reported Normalized Diluted E P S
-
Rent Expense Supplemental
-
Total Expenses
C$ 270.65K
Net Income From Continuing And Discontinued Operation
C$ -265.61K
Normalized Income
C$ -195.22K
Interest Expense
-
EBIT
C$ -265.61K
EBITDA
C$ -265.61K
Currency in CAD
Adaptogenics Health Corp. Earnings and Revenue History